Literature DB >> 9540407

Genetic blindness: current concepts in the pathogenesis of human outer retinal dystrophies.

K Gregory-Evans1, S S Bhattacharya.   

Abstract

Outer retinal dystrophies are the major causes of incurable blindness in the Western world. Understanding the etiology of retinal dystrophies has improved remarkably over the past decade. A number of genes, such as RHO, PDE-beta, RDS, TIMP3, MYO7A, RETGC1, RPGR, CRX and ABCR, are now known to be particularly important. Characterization of the genetic basis for disease is leading to new concepts of pathogenesis at the molecular and cellular levels. Such detailed understanding of disease processes is also stimulating a renewed interest in therapeutic strategies.

Entities:  

Mesh:

Year:  1998        PMID: 9540407     DOI: 10.1016/s0168-9525(98)01402-4

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  11 in total

1.  Genetic disorders of vision revealed by a behavioral screen of 400 essential loci in zebrafish.

Authors:  S C Neuhauss; O Biehlmaier; M W Seeliger; T Das; K Kohler; W A Harris; H Baier
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina.

Authors:  T Wang; G Steel; A H Milam; D Valle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Identification of photoreceptor genes affected by PRPF31 mutations associated with autosomal dominant retinitis pigmentosa.

Authors:  Daniel Mordes; Liya Yuan; Lili Xu; Mariko Kawada; Robert S Molday; Jane Y Wu
Journal:  Neurobiol Dis       Date:  2007-03-09       Impact factor: 5.996

4.  Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.

Authors:  Erin R Burnight; Manav Gupta; Luke A Wiley; Kristin R Anfinson; Audrey Tran; Robinson Triboulet; Jeremy M Hoffmann; Darcey L Klaahsen; Jeaneen L Andorf; Chunhua Jiao; Elliott H Sohn; Malavika K Adur; Jason W Ross; Robert F Mullins; George Q Daley; Thorsten M Schlaeger; Edwin M Stone; Budd A Tucker
Journal:  Mol Ther       Date:  2017-06-12       Impact factor: 11.454

5.  Q344ter mutation causes mislocalization of rhodopsin molecules that are catalytically active: a mouse model of Q344ter-induced retinal degeneration.

Authors:  Francis Concepcion; Jeannie Chen
Journal:  PLoS One       Date:  2010-06-02       Impact factor: 3.240

6.  Functional and morphological evaluation of blue light-emitting diode-induced retinal degeneration in mice.

Authors:  Gyu Hyun Kim; Hyung Il Kim; Sun-Sook Paik; Sung Won Jung; Seungbum Kang; In-Beom Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-08       Impact factor: 3.117

7.  Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.

Authors:  Jack M Sullivan; Edwin H Yau; Tiffany A Kolniak; Lowell G Sheflin; R Thomas Taggart; Heba E Abdelmaksoud
Journal:  J Ophthalmol       Date:  2011-06-30       Impact factor: 1.909

8.  Morphological and functional evaluation of an animal model for the retinal degeneration induced by N-methyl-N-nitrosourea.

Authors:  Eojin Jeong; Sun-Sook Paik; Sung Won Jung; Myung-Hoon Chun; In-Beom Kim
Journal:  Anat Cell Biol       Date:  2011-12-30

9.  Synaptogenesis and outer segment formation are perturbed in the neural retina of Crx mutant mice.

Authors:  Eric M Morrow; Takahisa Furukawa; Elio Raviola; Constance L Cepko
Journal:  BMC Neurosci       Date:  2005-01-27       Impact factor: 3.288

10.  A homozygous p.Glu150Lys mutation in the opsin gene of two Pakistani families with autosomal recessive retinitis pigmentosa.

Authors:  Maleeha Azam; Muhammad Imran Khan; Andreas Gal; Alamdar Hussain; Syed Tahir Abbas Shah; Muhammad Shakil Khan; Ahmed Sadeque; Habib Bokhari; Rob W J Collin; Ulrike Orth; Maria M van Genderen; A I den Hollander; Frans P M Cremers; Raheel Qamar
Journal:  Mol Vis       Date:  2009-12-03       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.